Skip to main content
Biotide Peptides

GHRH analogs and growth-hormone-secretagogue research peptides studied for the GH/IGF-1 axis.

GROWTH HORMONE STUDIES

Growth Hormone Axis research peptides: small protein strings for the brain-to-liver hormone chain

Drug makers hoped CJC-1295 and Ipamorelin could change the body's own growth hormone. See what came of the tests.

Biotide Peptides hero illustration

The pair has no fair test in people

Drug makers built these substances to change your body's own growth hormone. A small gland under your brain releases growth hormone, which travels through your blood and tells your liver to make IGF-1, a protein linked with growth and repair in your body. Doctors call that chain the growth hormone axis.

Peptides join a few amino acids. Your body uses these small pieces to make proteins. CJC-1295 keeps one natural hormone message going longer. Ipamorelin copies a different message that also reaches your growth gland. Researchers have never fairly tested the fixed CJC-1295 and Ipamorelin pair in people.

What surprised me was how much the claims outran the tests. You'll see who was tested, what rose or fell, and how many days the test lasted. None is approved medicine for you. This site doesn't sell the drugs, give medical advice, or provide a human dose.

A research label doesn't make a drug approved

Researchers may test a peptide in lab-grown cells, animals, or a few people, and those tests can show a body change without making the substance approved medicine for you.

These three don't put growth hormone into your body; they prompt the growth gland to release its own supply in bursts, yet a burst on a blood test isn't proof that your sleep, strength, or health will improve. Nor can a burst show whether years of use are safe for you.

Any amount shown here belongs only to its study. One test, for example, used 30 micrograms for each kilogram of body weight in healthy adults. That's a study fact, not a plan for your care.

The pair has the least proof of the three

When a health claim covers the blend, ask which drug was actually tested, because a finding for one drug can't prove the pair works for you or is safe.

  • CJC-1295 / Ipamorelin puts two hormone messages together. Cells in a dish and healthy men had a larger growth-hormone burst when both messages were used [5][7]. The fixed pair itself has no fair trial.
  • CJC-1295 was built to remain in blood. One shot raised growth hormone for six or more days in healthy adults. After more than one shot, IGF-1, the liver's growth protein, stayed high for up to 28 days [3]. If a label says DAC, CJC-1295 has a hook that grips a blood protein and helps it last [4].
  • Ipamorelin starts a shorter hormone burst. Early tests found little change in cortisol, a hormone that helps your body answer stress, or two other hormones [6]. Its only Phase 2 trial—an early human check for benefit and short-term harm—had 114 adults after bowel surgery. Ipamorelin failed the main test [14].

The drug pages give you fuller facts. The comparison keeps human findings apart from animal and cell work, helping you judge claims about your health.

The small numbers lead to the papers

Each finding comes from a paper or review. A small number in brackets leads to the reference list. There you can see who wrote the paper, its year, and where you can read it.

Each page names the test group, whether people, animals, or lab-grown cells. You learn what changed and what stayed unknown, which keeps a lab idea apart from a human result that may matter to you. IGF-1 remains only when it names a blood-test result for you.

The CJC-1295 Pair Hasn't Had a Fair Human Trial

The CJC-1295 Pair Hasn't Had a Fair Human Trial

One drug keeps the brain's growth-hormone message going. The other copies a hunger-hormone message that also reaches the growth gland. No fair trial gave people this fixed pair.

See the separate tests →
CJC-1295 Changed Blood Tests for Days

CJC-1295 Changed Blood Tests for Days

Makers built the drug to last in blood. In healthy adults, it raised growth hormone and kept IGF-1, a growth protein made by the liver, high for up to 28 days.

See the human results →
Ipamorelin Failed Its Main Human Test

Ipamorelin Failed Its Main Human Test

Makers wanted Ipamorelin to release growth hormone without raising other hormones. Animal tests found that narrow effect. The one larger test in people missed its main goal.

See the animal and human tests →